Rigel Pharma (RIGL) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $42.58 --0%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $16.74 million versus the consensus estimate of $17.54 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
